康希諾生物-B(06185.HK)委任桂水發及劉建忠為獨立非執行董事
格隆匯11月29日丨康希諾生物-B(06185.HK)此宣佈:桂水發已獲委任為公司獨立非執行董事,並當選為薪酬與考核委員會主席及提名委員會成員;及劉建忠已獲委任為公司獨立非執行董事,並當選為薪酬與考核委員會成員及提名委員會主席。
於臨時股東大會結束後,Pierre Armand MORGON不再擔任公司獨立非執行董事、薪酬與考核委員會主席及提名委員會成員。Luis BARRETO博士不再擔任公司獨立非執行董事、薪酬與考核委員會成員及提名委員會成員。
於2019年11月29日召開的董事會會議結束後,Xuefeng YU不再擔任提名委員會主席,並將繼續擔任提名委員會成員。
此外,李江峯已獲委任為公司監事及監事會主席。於臨時股東大會結束後,朱際翔不再擔任公司監事及監事會主席。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.